DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 8-12

  Gonzalez Ramirez, Diego ^a   Zuniga Charles, Miguel ^a   Narro Juarez, Antonio ^a   Molina Recio, Yolanda ^a   Hurlbut, Katherine M ^b   Dart, Richard C ^b   Aposhian, H Vasken ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^c University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCUROUS CHLORIDE; UNITHIOL;

ADULT; ARTICLE; BODY BURDEN; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; MALE; MERCURIALISM; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST;

ADULT; BODY BURDEN; CHELATING AGENTS; FEMALE; HUMANS; MALE; MERCURY; MERCURY COMPOUNDS; MIDDLE AGED; OCCUPATIONAL EXPOSURE; UNITHIOL;

EID: 0032463040     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Aaseth J, Jacobsen D, Andersen O and Wickstrom E (1995) Treatment of mercury and lead poisoning with dimercaptosuccinic acid and sodium dimercaptopropane-sulfonate: A review. Analyst 120:23-38.
2. Aposhian HV (1983) DMSA and DMPS: Water-soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol 23:193-215.
3. Aposhian HV, Bruce DC, Alter W, Dart RC, Hurlbut KM and Aposhian MM (1992b) Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: Correlation with dental amalgam score. FASEB J 6:2472-2476.
4. Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu ZF, Hurlbut KM, Junco-Munoz P, Dart RC and Aposhian MM (1995) Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 97:23-38.
5. Aposhian HV, Maiorino RM, Rivera M, Bruce DC, Dart RC, Hurlbut KM, Levine DJ, Zheng W, Fernando Q, Carter D and Aposhian MM (1992a) Human studies with the chelating agents DMPS and DMSA. Clin Toxicol 30:505-528.
6. Campbell JR, Clarkson TW and Omar MD (1986) The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning. JAMA 256:3127-3130.
7. Clarkson TW, Hursh JB, Sager PR and Syversen TLM (1988) Mercury, in Biological Monitoring of Toxic Metals, (Clarkson TW, Friberg L, Nordberg GF and Sager PR eds) pp 199-246, Plenum Press, New York.
8. Goldwater LJ (1972) Mercury: The History of Quicksilver. York Press, Baltimore.
9. Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Aposhian MM, Dart RC, Gama JHD, Echeverria D, Woods JS and Aposhian HV (1995) Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. J Pharmacol Exp Ther 272:264-274.
10. Gotelli CA, Astolfi E, Cox C, Cernichiari E, and Clarkson TW (1985) Early biochemical effects of an organic mercury fungicide on infants: "Dose makes the poison." Science 227:638-640.
11. Goyer RA (1996) Toxic effects of metals, in Casarett and Doull's Toxicology. The Basic Science of Poisons (Klaassen CD ed) McGraw-Hill. New York.
12. Hoover TD and Aposhian HV (1983) BAL increases the arsenic-74 content of rabbit brain. Toxicol Appl Pharmacol 70:160-162.
13. Hurlbut KM, Maiorino RM, Mayersohn M, Dart RC, Bruce DC and Aposhian HV (1994) Determination and metabolism of dithiol chelating agents. XVI. Pharmacokinetics of sodium 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers. J Pharmacol Exp Ther 268:662-668.
14. Kang-Yum E and Oransky S (1992) Chinese patent medicine as a potential source of mercury poisoning. Vet Hum Toxicol 34:235-238,
15. Kemper FH, Jekat FW, Bertram HP and Eckard R (1990) New chelating agents, in Basic Science in Toxicology, Proceedings of the 5th International Congress of Toxicology, England, 1989 (Volans GN, Sims J, Sullivan FM and Turner P eds) Taylor & Francis Ltd., London.
16. Klaassen CD (1996) Heavy metals and heavy-metal antagonists, in The Pharmacological Basis of Therapeutics (Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Gilman AG eds) pp 1649-1671, McGraw-Hill, New York.
17. Klimova KK (1958) Pharmacology of a new Unithiol antidote. Farmakol Toksicol (Moscow) 21:53-59.
18. Lombera-Gonzalez M, Albuerne-Pina A and Saldate-Castaneda O (1996) Intoxicacion por mercurio debido al uso de cremas de belleza. Epidemiologia (Mex) Sist. Nal. de Vigilancia Epidemiol S Sa 13:1-2.
19. Magos L (1975) Mercury and mercurials. Br Med Bull 31:241-245.
20. Maiorino RM, Dart RC, Carter DC and Aposhian HV (1991) Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans. J Pharmacol Exp Ther 259:808-814.
21. Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z-F, Hurlbut KM, Aposhian MM, Dart RC, Woods JS, Ostrosky-Wegman P, Gonsebatt ME and Aposhian HV (1996) Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride. J Pharmacol Exp Ther 277:938-944.
22. Medical Information Systems, Inc. (1996) Normal Values Guide, Stamford, CT.
23. 2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. Int Arch Allergy Appl Immunol 90:47-53.
24. Schiele R, Schaller KH and Weltle D (1989) Mobilization of mercury reserves in the organism by means of DMPS (Dimaval). Occup Med Soc Med Prevent Med 24:249-251.
25. Villanacci JF, Beauchamp R, Perrotta DM, Hendriks K, Rodriguez M, Dutton RJ, Sutton KM, Simpson DM, Richards K, Nelson F, Crespin CM, Sewell CM, Bartzen M, Senini L, Richardson S, Waterman S, Lombera MG, Rumz MA, Cravioto P, Saldate O, Flores G (1996) Mercury poisoning associated with beauty cream - Texas, New Mexico and California, 1995-1996. Archives of Dermatology 132:1533-1534.
26. Warkany J (1966) Acrodynia: Postmortem of a disease. Amer J Dis Child 112:147-156.
27. Warkany J and Hubbard DM (1951) Adverse mercurial reactions in the form of acrodynia and related conditions. Am J Dis Child 81:335-373.
28. WHO: IPCS (1991) Environmental Health Criteria, 118, Inorganic Mercury. World Health Organization Geneva.
29. Woods JS, Calas CA, Aicher LD, Robinson BH and Mailer C (1990) Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide. Mol Pharmacol 38:253-260.